Fukushima, Japan

Kouichi Watanabe

This inventor holds 1 USPTO granted patent. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1997.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kouichi Watanabe. Retrieved from https://idiyas.com/inventor/kouichi-watanabe-hnynkp74

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 1997

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Kouichi Watanabe

Introduction

Kouichi Watanabe is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of benzodiazepine derivatives. His work has led to advancements that are crucial for various medical applications.

Latest Patents

Watanabe holds a patent for the crystal form of benzodiazepine derivatives. This innovation is essential for enhancing the efficacy and stability of these compounds in pharmaceutical formulations. His patent portfolio includes 1 patent that showcases his expertise in this specialized area.

Career Highlights

Kouichi Watanabe is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in research and development. His role at the company has allowed him to focus on innovative solutions that address medical needs. His contributions have been recognized within the industry, marking him as a key figure in pharmaceutical innovation.

Collaborations

Watanabe has collaborated with various professionals in his field, including his coworker Makoto Nakamura. These partnerships have fostered a creative environment that encourages the exchange of ideas and advancements in their research.

Conclusion

Kouichi Watanabe's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly in the area of benzodiazepine derivatives, highlight the importance of research and development in improving medical treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…